Caris Life Sciences, Inc. (CAI)
25.63
-0.75
(-2.84%)
USD |
NASDAQ |
Aug 28, 16:00
25.63
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Cash from Operations (Quarterly) : 28.48M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.48M |
| March 31, 2026 | 32.88M |
| December 31, 2025 | 37.07M |
| September 30, 2025 | 62.42M |
| June 30, 2025 | 7.288M |
| Date | Value |
|---|---|
| March 31, 2025 | -31.34M |
| December 31, 2024 | -38.92M |
| September 30, 2024 | -69.43M |
| June 30, 2024 | -62.93M |
| March 31, 2024 | -73.92M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| CareDx, Inc. | 30.60M |
| Myriad Genetics, Inc. | -8.30M |
| BioRestorative Therapies, Inc. | -3.808M |
| Natera, Inc. | 54.79M |
| Exagen, Inc. | 3.988M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -122.19M |
| Cash from Financing (Quarterly) | -36.90M |
| Free Cash Flow | 116.25M |
| Free Cash Flow Per Share (Quarterly) | 0.0226 |
| Free Cash Flow to Equity (Quarterly) | -15.04M |
| Free Cash Flow to Firm (Quarterly) | 15.98M |
| Free Cash Flow Yield | 1.61% |